These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 15032554

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. HIV-reverse transcriptase inhibition: inclusion of ligand-induced fit by cross-docking studies.
    Ragno R, Frasca S, Manetti F, Brizzi A, Massa S.
    J Med Chem; 2005 Jan 13; 48(1):200-12. PubMed ID: 15634014
    [Abstract] [Full Text] [Related]

  • 3. Mutational analysis of trp-229 of human immunodeficiency virus type 1 reverse transcriptase (RT) identifies this amino acid residue as a prime target for the rational design of new non-nucleoside RT inhibitors.
    Pelemans H, Esnouf R, De Clercq E, Balzarini J.
    Mol Pharmacol; 2000 May 13; 57(5):954-60. PubMed ID: 10779379
    [Abstract] [Full Text] [Related]

  • 4. Docking and quantitative structure-activity relationship studies for the bisphenylbenzimidazole family of non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Lagos CF, Caballero J, Gonzalez-Nilo FD, David Pessoa-Mahana C, Perez-Acle T.
    Chem Biol Drug Des; 2008 Nov 13; 72(5):360-9. PubMed ID: 19012572
    [Abstract] [Full Text] [Related]

  • 5. Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
    Fattorusso C, Gemma S, Butini S, Huleatt P, Catalanotti B, Persico M, De Angelis M, Fiorini I, Nacci V, Ramunno A, Rodriquez M, Greco G, Novellino E, Bergamini A, Marini S, Coletta M, Maga G, Spadari S, Campiani G.
    J Med Chem; 2005 Nov 17; 48(23):7153-65. PubMed ID: 16279773
    [Abstract] [Full Text] [Related]

  • 6. Understanding the basis of resistance in the irksome Lys103Asn HIV-1 reverse transcriptase mutant through targeted molecular dynamics simulations.
    Rodríguez-Barrios F, Gago F.
    J Am Chem Soc; 2004 Dec 01; 126(47):15386-7. PubMed ID: 15563158
    [Abstract] [Full Text] [Related]

  • 7. The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs.
    Auwerx J, Van Nieuwenhove J, Rodríguez-Barrios F, de Castro S, Velázquez S, Ceccherini-Silberstein F, De Clercq E, Camarasa MJ, Perno CF, Gago F, Balzarini J.
    FEBS Lett; 2005 Apr 25; 579(11):2294-300. PubMed ID: 15848161
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of a bound non-nucleoside RT inhibitor on the dynamics of wild-type and mutant HIV-1 reverse transcriptase.
    Zhou Z, Madrid M, Evanseck JD, Madura JD.
    J Am Chem Soc; 2005 Dec 14; 127(49):17253-60. PubMed ID: 16332074
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of NNRTIs on HIV reverse transcriptase dimerization.
    Tachedjian G, Goff SP.
    Curr Opin Investig Drugs; 2003 Aug 14; 4(8):966-73. PubMed ID: 14508881
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rational approaches for the design of effective human immunodeficiency virus type 1 nonnucleoside reverse transcriptase inhibitors.
    Ribone SR, Quevedo MA, Madrid M, Briñón MC.
    J Chem Inf Model; 2011 Jan 24; 51(1):130-8. PubMed ID: 21133347
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Flexible docking of pyridinone derivatives into the non-nucleoside inhibitor binding site of HIV-1 reverse transcriptase.
    Medina-Franco JL, Rodríguez-Morales S, Juárez-Gordiano C, Hernández-Campos A, Jiménez-Barbero J, Castillo R.
    Bioorg Med Chem; 2004 Dec 01; 12(23):6085-95. PubMed ID: 15519154
    [Abstract] [Full Text] [Related]

  • 17. Structure based activity prediction of HIV-1 reverse transcriptase inhibitors.
    de Jonge MR, Koymans LM, Vinkers HM, Daeyaert FF, Heeres J, Lewi PJ, Janssen PA.
    J Med Chem; 2005 Mar 24; 48(6):2176-83. PubMed ID: 15771460
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.